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Paeoniflorin exerts a nephroprotective effect
on concanavalin A-induced damage through
inhibition of macrophage infiltration
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Abstract
Background: It is well established that macrophage infiltration is involved in concanavalin A (conA)-induced liver
injury. However, the role of macrophages in conA-induced renal injury remains unknown. The aims of this study
were to investigate macrophage infiltration in conA-induced renal injury and determine whether paeoniflorin (PF)
could inhibit macrophage infiltration into the kidney.
Methods: BALB/C mice were pre-treated with or without PF 2 h (h) before conA injection. At 8 h after con A
injection, all the mice were sacrificed; The liver and kidney histology were studied. The renal CD68 expression was
detected by immunohistochemical and real-time PCR analysis. The level of expression of C-X-C chemokine receptor
type 3 (CXCR3) was analyzed by western blot, immunohistochemical and real-time PCR. The pathophysiological
involvement of CXCR3 in macrophage infiltration were investigated using dual-colour immunofluorescence
microscopy.
Results: PF administration significantly reduced the elevated serum levels of alanine transaminase (ALT), blood urea
nitrogen (BUN), creatinine (Cr) and the severity of liver and renal damage compared with that in the conA-vehicle
group. PF administration inhibited the increase in renal IL1β mRNA expression and concentration. Furthermore,
immunohistochemical analysis showed that macrophages secreted CXCR3 in the kidneys of the conA-vehicle mice.
Immunofluorescence microscopy demonstrated CXCR3 bound tightly to C-X-C motif ligand 11 (CXCL11) in the
kidneys of the conA-vehicle mice and showed that PF treatment could suppress CXCR3/CXCL11 over-activation.
Conclusions: Macrophage infiltration was a notable pathological change in the kidneys of conA-treated mice. PF
administration attenuated conA-induced renal damage, at least in part, by inhibiting the over-activated CXCR3/
CXCL11 signal axis.
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Background
ConA-induced liver injury is a well-established mouse
model used to detect immune cell-mediated acute hepa-
titis, and closely resembles the pathology of human
autoimmune hepatitis [1]. ConA-induced liver injury is
characterised by a marked increase in plasma alanine
transaminase (ALT) levels from 8 to 24 h after injection,
as well as simultaneous hepatic infiltration by CD4+ T
immune cells, natural killer T cells (NKT), Kupffer cells,
and neutrophils [2]. The activation of lymphocytes and
production of inflammatory cytokines and chemokines
are well studied in conA-induced liver injury [3, 4]; how-
ever, it remains unclear whether the kidney is damaged
in conA-treated mice.
Paeoniflorin (PF), a monoterpene glycoside, is the prin-
cipal bioactive component of Radix Paeoniae Rubra, a
traditional Chinese herbal medicine [5]. PF inhibits hep-
atocyte apoptosis and the potential mechanism underlying
this is associated with the regulating mediators in endo-
plasmic reticulum (ER) stress and mitochondria-
dependent pathways [6]. PF reduces dextran sodium
sulphate (DSS)-induced colitis by suppressing the
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expression of toll-like receptor 4 (TLR4) and reducing the
activation of nuclear factor-kappa B (NF-κB) and
mitogen-activated protein kinase (MAPK) pathways [7].
PF has also been used for the treatment of liver fibrosis in-
duced by the Schistosomiasis japonica egg [8]. We have re-
cently reported that PF inhibits liver fibrosis induced by
dimethylnitrosamine (DMN) in rats [9]. Renal macro-
phages, similar to hepatic Kupffer cells, increased signifi-
cantly after two weeks of DMN treatment, then decreased
after four weeks of DMN administration. Therefore, PF
could inhibit renal macrophage activation in DMN-
induced liver fibrosis. As a result, it has been hypothesised
that the kidney is damaged in conA-induced hepatitis, and
PF could reduce conA-induced renal damage by inhibiting
macrophage infiltration. It was investigated 1) whether the
kidney was damaged, and if so, the macrophage involve-
ment was assessed; 2) whether PF reduced renal damage
and macrophage infiltration in conA-induced injury; and
3) whether the CXCR3/CXCL11 signalling pathway was
involved in macrophage infiltration in conA-induced in-
jury. This study describes a newly discovered effect of PF




Paeoniflorin (PF, >95 % purity), DAPI fluorescent stain,
and conA type IV were obtained from Sigma (St Louis,
MO, USA). The SABC kit for immunohistochemical
analysis was obtained from Boster (Wuhan, China). The
IL1β ELISA kit was from R&D system (Minneapolis,
MN, USA). The antibodies used for the immunohisto-
chemical and western blot analyses were rabbit poly-
clonal IL1β (sc-7884), goat polyclonal monocyte
chemotactic protein 1 (MCP1) (sc-1785), rabbit poly-
clonal F4/80 (sc-25830), mouse monoclonal CXCR3
(sc-137140) and rabbit polyclonal CXCL11 (sc-28874)
purchased from Santa Cruz Biotechnology (La Jolla,
CA, USA). Mouse monoclonal CD68 (MCA31R) was
obtained from Serotec (Oxfordshire, OX51GE, UK).
Secondary fluorescence-labelling goat anti-mouse Cy3
and goat anti-rabbit FITC second antibodies were ob-
tained from Jackson (West Grove, PA, USA).
Ethics statement
All of the study protocols complied with the current eth-
ical considerations of Shanghai University of Traditional
Chinese Medicine’s Animal Ethic Committee and the
procedural and ethical guidelines of the Chinese Animal
Protection Act, which is in accordance with the National
Research Council criteria. All animal experiments and
procedures were reviewed and approved by the Institu-
tional Animal Care and Use Committee (IACUC) of
Shanghai University of Traditional Chinese Medicine
and were performed in accordance with the relevant
guidelines and regulations.
Animals
60 Female BALB/C mice at (18 ± 2 g) were supplied by
the Central Animal Care Facility of Shanghai University
of Traditional Chinese Medicine and housed in an air-
conditioned room at 25 °C with a 12 h darkness/light
cycle. The mice received humane care with unlimited
access to food and water during the study.
ConA-induced tissue damage in mice
Mice received conA injection via the tail vein at 15 mg/kg
body weight. PF (6 mg/kg, 30 mg/kg, or 150 mg/g)
was orally administered 2 h before conA injection
and control mice received vehicle (distilled water) or
PF (30 mg/kg). There was 10 mice in each group. At 8 h
after conA injection, all the mice were euthanized under
2 % pentobarbital sodium, and all efforts were made to
minimise suffering; kidney and liver samples were taken
for the following investigations.
Histology analysis
The kidney and liver specimens were preserved in
4 % paraformaldehyde and dehydrated in a graded al-
cohol series. The specimens were embedded in paraf-
fin blocks, cut into 3 μm-thick sections, and placed
on glass slides. The sections were then stained with
haematoxylin-eosin (HE).
Liver and kidney function tests
Serum levels of ALT, BUN, and Cr were measured in
samples obtained at the end of the experiment. Activity
and content were evaluated using a commercial clinical
test kit (Jiancheng Institute of Biotechnology, Nanjing,
China) according to manufacturer’s instructions.
Measurement of cytokine levels in the kidneys
The kidneys were homogenised in 5 ml ice-cold physio-
logical saline and the supernatant was obtained by cen-
trifugation at 3000 g for 10 min. Samples were analysed
and absolute values were obtained by comparison with
standards.
Immunohistochemistry
Embedded tissue was deparaffinised in xylene and rehy-
drated. Microwave antigen retrieval was carried out for
5 min before quenching the peroxidase with 3 % H2O2
in phosphate-buffered saline (PBS) for 10 min at room
temperature. The sections were blocked using 5 % BSA
for 30 min at 37 °C, and then incubated with the re-
spective primary antibodies (anti-CD68, anti-IL1β, anti-
MCP1, and anti-CXCR3) at room temperature for 1 h.
After washing with PBS, sections were subsequently
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incubated with species-specific biotinylated secondary
antibodies at room temperature for 30 min. After washing,
the sections were stained with 3,3′-diaminobenzidine
(DAB). Counterstaining was performed with haematoxylin
before dehydration and mounting.
Immunofluorescent staining
Double staining for F4/80 and CXCR3, and, CXCR3 and
CXCL11 were performed on paraffin sections. Sections
were deparaffinised in xylene, rehydrated and incubated
with protease K (20 μg/ml) for 10 min at 37 °C. There-
after, the slides were incubated with 5 % BSA for 30 min
followed by incubation with anti-F4/80 primary antibody
at 37 °C for 1 h. Slides were then washed three times
with PBS and incubated with the secondary FITC-
conjugated Affinipure goat anti-rabbit antibody for
30 min. After washing, the sections were incubated with
the CXCR3 antibody followed by Cy3-conjugated Affini-
pure goat anti-mouse antibody. Nuclei were labelled
with DAPI. Imaging analyses were performed using an
Olympus (Osaka, Japan) BX43 system.
Real-time PCR analysis
Total RNA was extracted from kidney tissue using Tri-
zol reagent (Invitrogen, Carlsbad, CA). A high-capacity
cDNA reverse transcription kit (Applied Biosystems,
Forster City, CA) was used to synthesise the cDNA. PCR
amplification was conducted in 10 μl of solution con-
taining 3 μl cDNA, 5 μl SYBR mixture, 1.6 μl H2O, and
0.4 μl primer (10 μM). The primers used were as follows:
CXCR3, 5′-TCTCGTTTTCCCCATAATCG-3′ (forward)
and 5′-AGCCAAGCCATGTACCTTGA-3′ (reverse); CX
CL11, 5′-CATTTTGACGGCTTTCATCC-3′ (forward)
and 5′-AAGGTCACAGCCATAGCCCT-3′ (reverse). CD
68, 5′-ACCGCCATGTAGTCCAGGTA-3′ (forward) and
5′-ATCCCCACCTGTCTCTCTCA-3′ (reverse). MCP1
5′-ATTGGGATCATCTTGCTGGT-3′ (forward) and 5′-
CCTGCTGTTCACAGTTGCC-3′(reverse). IL1β 5′ -GG
CTCATCTGGGATCCTCTC-3′ (forward) and 5′-TCAT
CTTTTGGGGTCCGTCA-3′ (reverse).18 S rRNA, 5′-A
GTCCCTGCCCTTTGTACAC-3′ (forward) and 5′ -CGA
TCCGAGGGCCTCACTA-3′ (reverse). Amplification steps
consisted of 40 cycles of denaturation at 94 °C for 40 s,
annealing at 55 °C for 40 s, and extension at 72 °C
for 40 s using a DNA cycler CFX96 real-time system
(Bio Rad, Hercules, CA, USA).
Western blot analysis
Kidney samples were prepared in ice-cold radio-immune
precipitation assay (RIPA) buffer with protease inhibi-
tors. Samples were centrifuged for 10 min at
12,000 rpm. The supernatant was collected, and the pro-
tein concentration was measured using a BCA commer-
cial kit. Protein lysates were separated by SDS-PAGE
and subsequently transferred onto nitrocellulose mem-
branes. Membranes were blocked with 5 % non-fat dry
milk buffer and incubated with antibodies against CXCR3
and CXCL11. A secondary antibody was used for chemilu-
minescent detection. The loading accuracy was evaluated
by monoclonal antibody against GAPDH.
Statistical analysis
Each experiment was performed at least three independ-
ent times. All the results are expressed as mean ± s.d.
The statistical test was performed with SPSS software
version 18.0. Groups were compared using one-way ana-
lysis of variance with Dunnett’s multiple comparison test
or the Student-Newman-Keuls test. P < 0.05 was consid-
ered statistically significant.
Results
Suppressed conA-induced liver injury in PF-treated mice
To test the effects of PF on conA-induced mouse hepa-
titis, PF (6 mg/kg, 30 mg/kg, or 150 mg/kg) was intra-
peritoneally administered. Light microscopy examination
showed that 8 h after intravenous injection of conA
(15 mg/kg body weight) severe liver histopathology was
induced, i.e. extensive areas of hepatocyte necrosis and
marked sinusoidal hyperaemia associated with haemor-
rhage. On the other hand, mice pre-treated with PF
(30 mg/kg and 150 mg/kg) showed only minor liver
damage (Fig. 1a). Serum ALT levels were also measured
after conA injection. As shown in Fig. 1b, serum ALT
levels were significantly lower in the conA-PF (30 mg/kg
and 150 mg/kg) group compared with conA-vehicle mice.
PF attenuated conA-induced renal damage
To assess kidney damage, renal function and renal histo-
pathological analysis was performed. The levels of serum
BUN and Cr increased significantly 8 h after conA treat-
ment (Fig. 1c and 1d). PF (30 mg/kg and 150 mg/kg)
showed attenuated renal injury, i.e. decreased serum
BUN and Cr levels (Fig. 1c and 1d).
Kidney in the non-conA-vehicle and non-conA-PF
group showed normal architecture. After 8 h of conA
treatment, massive renal tubular epithelial cell necrosis
and intense pro-inflammatory cytokine infiltration were
found (Fig. 1a). PF (30 mg/kg and 150 mg/kg) showed
attenuated tubular epithelial cell necrosis and pro-
inflammatory cell infiltration (Fig. 2).
These results suggest that the kidney is damaged
after conA administration. PF (30 mg/kg dose and
150 mg/kg) has shown efficacy in conA-induced liver
and renal injury in mice. Therefore, PF was selected
at a dose of 30 mg/kg for exploring the mechanism
of action in the following study.
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PF inhibits renal macrophage and pro-inflammatory
cytokines
Macrophage involvement in conA-induced renal injury was
assessed. As shown in Fig. 3a, CD68-positive macrophages
were at low levels in non-conA kidneys. CD68-positive
macrophages, with strong staining, appeared in the renal
interstitium and glomerulus in conA-vehicle mouse kid-
neys. PF pre-treatment could inhibit conA-induced CD68
expression.
Consistent with the results of immunostaining of
CD68 (Fig. 3a), increased expression of CD68 was con-
firmed by real-time PCR analysis (Fig. 3b). Real-time
PCR showed that CD68 mRNA was up-regulated around
3.3-fold 8 h after conA treatment. In the conA-PF group,
there was a significant reduction in the CD68 mRNA ex-
pression compared to the conA-vehicle group (P < 0.01).
As presented in Fig. 3c, in conA-vehicle kidneys, the
expression of IL1β increased significantly (P < 0.01) by
more than 6.5-fold compared with the non-conA group.
However, PF attenuated IL1β expression compared with
conA-vehicle kidneys (P < 0.01). This was also confirmed
by ELISA (Fig. 3d). In conA-vehicle kidneys, MCP1
mRNA expression increased significantly compared with
the non-conA group. PF could inhibit the elevated
MCP1 mRNA levels. These results suggest macrophage
infiltration into kidneys in conA-induced injury.
IL1β and MCP1 were derived mainly from renal epithelial
cells and not macrophages in conA-induced renal injury
It has been well reported that pro-inflammatory cy-
tokines are derived from macrophages [10], and re-
sults in this study showed IL1β and MCP1 increased
Fig. 1 The hepatorenal protective effect of paeoniflorin (PF) in conA-induced mouse model. a Effect of PF on light micrographic changes in the
liver after conA injection (×100). b Effect of PF on serum ALT activity in conA-induced liver injury in mice. c Effect of PF on serum BUN and Cr
content. d In conA-induced liver injury in mice, PF (6 mg/kg, 30 mg/kg, and 150 mg/kg) was administered orally 2 h before injection of conA or
vehicle for 8 h. The number in HE staining, serum ALT, and renal function was as the same as the animal number in each group. The data
represented the mean ± SD #P < 0.05, ##P < 0.01, vs non-conA-vehicle mice, *P < 0.05, * *P < 0.01, vs conA-vehicle mice
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significantly after conA administration. It was con-
firmed whether these pro-inflammatory cytokines
were produced from the macrophages using immno-
histochemical analysis.
As shown in Fig. 4, tubular epithelial cells were weakly
positive for IL1β and MCP1 in non-conA mice. IL1β and
MCP1 were located in tubular epithelial cells with strong
staining in conA-vehicle mouse kidneys. The strong
stained IL1β and MCP1 were suppressed in conA-PF
mice. The pro-inflammatory chemokines such as IL1β
and MCP1 were almost expressed in tubular epithelial
cells, but not in macrophages.
Fig. 2 Morphology of kidneys and the protective effect of PF in conA-induced mouse model. Renal HE staining (×400). Arrow means renal injury.
PF (6 mg/kg, 30 mg/kg, and 150 mg/kg) was administered orally 2 h before injection of conA or vehicle for 8 h. The number in renal HE staining
was as the same as the animal number in each group
Fig. 3 Effect of PF on macrophage infiltration and pro-inflammatory cytokines in conA-induced renal damage. a CD68 immunohistochemical
staining (×400, n = 3), Brown staining indicates immunopositivity. b real-time PCR showing the change in CD68 (n = 6), (c) IL1β mRNA expression
by real-time PCR analysis (n = 6), (d) IL1β content analysis by ELISA analysis, The number in ELISA was as the same as the animal number in each
group. e MCP1 mRNA analysis by real-time PCR (n = 6). PF (30 mg/kg) was administered orally 2 h before injection of conA or vehicle for 8 h
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CXCR3 increased in kidneys after conA administration
Chemokines play an important role in macrophage accu-
mulation at the inflammatory site. CXCR3 and its li-
gands have been suggested to be one of the most
important chemokine axes that promote the arrival of
cells into the injured tissues [11]. As shown in Fig. 5a,
CXCR3 was weakly stained in non-conA mouse kidneys.
In conA-vehicle mouse kidneys, CXCR3 increased
significantly and was largely expressed in the renal inter-
stitium, and not in the tubular epithelial cells. In conA-PF
mouse kidneys, CXCR3 was suppressed compared with
the conA-vehicle group; this was also confirmed by real-
time PCR (Fig. 5b).
The mRNA levels of CXCL11 in the kidneys were
assessed using quantitative PCR (Fig. 5c). Higher levels
of CXCL11 were recorded in the samples from conA-
Fig. 4 IL1β (upper) and MCP1 (lower) mostly expressed in tubular epithelial cells in conA-induced renal injury. PF (30 mg/kg) was administered
orally 2 h before injection of conA or vehicle for 8 h. (×400, n = 3)
Fig. 5 Effect of PF on CXCR3 and CXCL11 expression in conA-induced renal injury. a CXCR3 immunohistochemical staining (×400, n = 3). b CXCR3
mRNA expression was detected using real-time PCR (n = 6), c CXCL11 mRNA expression was detected using real-time PCR (n = 6), d CXCR3 and
CXCL11 were detected by western-blot (n = 4). PF (30 mg/kg) was administered orally 2 h before injection of conA or vehicle for 8 h
Liu et al. Diagnostic Pathology  (2015) 10:120 Page 6 of 10
treated mice than in non-conA samples. In addition,
mice in the conA-PF group showed lower CXCR3 levels
compared with the conA-vehicle group. This was also
confirmed by western blot analysis (Fig. 5d).
CXCR3 and macrophages co-localise in conA-treated
mouse kidneys
CXCR3 originated mostly from interstitial cells. CXCR3
can also originate from macrophages and plays an im-
portant role in conA-induced renal damage. To this end,
immunofluorescence analysis was performed. Double
staining for F4/80 and CXCR3 showed that F4/80-
positve macrophages were producers of CXCR3 in
conA-treated kidneys. As expected, there were a few
numbers of double F4/80 and CXCR3-positive cells
(Fig. 6). Almost all F4/80-positive macrophages were
found to be CXCL11-positive. In contrast, a lower num-
ber of infiltrating F4/80-positive macrophages, that also
had lower expression levels for CXCR3, was observed in
the kidneys of conA-PF mice. These results showed that
macrophages are the main producer of CXCR3 in conA-
induced renal injury.
Interactions of CXCR3 and CXCL11 observed in conA-
treated mouse kidneys
Because the number of macrophages is characteristically
increased in the conA-vehicle kidneys and macrophages
express CXCR3, it was hypothesised that the overpro-
duction of CXCL11 may be involved in macrophage re-
cruitment to the injured kidneys in conA-treated mice.
To this end, the presence of CXCR3 with CXCL11 was
analysed through immunofluorescence microscopy. As
shown in Fig. 7, clear evidence was provided that there
was interaction between CXCR3 and CXCL11 in conA-
induced damage. In non-conA mice, CXCR3- and
CXCL11-positive cells were separated from each other
indicating minimal interaction (Fig. 7). Numbers of
CXCL11- and CXCR3-positive cells were significantly
Fig. 6 Renal sections were stained using immunofluorescence staining consisting of F4/80 (green), CXCR3 (red), and DAPI (blue) to determine the
relationship between macrophages and CXCR3 expression in conA-induced renal injury. Arrow indicates CXCR3 derived from macrophages
(×400, n = 3). PF (30 mg/kg) was administered orally 2 h before injection of conA or vehicle for 8 h
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increased compared with non-conA kidneys 8 h after
conA treatment (Fig. 7). CXCL11-positive cells were
mostly expressed in tubular epithelial cells, and the
CXCR3-positive cells were bound to CXCL11-positive
cells. These findings suggest that the production of
CXCL11 by the tubular epithelium is responsible for the
recruitment of CXCR3-positive cells. PF suppressed the
interactions of CXCL11 and CXCR3.
Discussion
In this study, it was demonstrated that PF protected
mice from renal damage in conA-induced injury, and
the mechanism of PF was shown to be closely associated
with its suppressive effect on the CXCR3/CXCL11 che-
mokine axis in macrophage recruitment.
Intravenous injection of conA (at a dose of more than
10 mg/kg body weight) in mice can cause severe liver in-
jury with high mortality rate [12], which is similar to acute
hepatic failure. Experimental and clinical studies have
demonstrated that liver diseases with liver dysfunction, es-
pecially in hepatic failure, are frequently accompanied by
acute kidney injury (AKI) [13]. For example, renal damage
consists of proximal tubular nephrosis in acute hepatic
coma [14]. Furthermore, patients with acute hepatic failure
usually suffer renal damage with higher levels of creatinine
[14]. The kidney was damaged with higher tryptophan
levels in the lipopolysaccharide (LPS)-induced acute hepatic
failure model [15]. All these reports confirm that the kid-
neys are damaged in acute hepatitis. The data presented
here also shows that BUN and Cr increases significantly
after 8 h of conA administration. Renal tubular ne-
crosis and inflammatory cell infiltration were also ob-
served by HE staining. From these results, it could be
concluded that the kidneys were also damaged in
conA-treated mice.
ConA-induced liver injury in mice is characterised by
inflammatory infiltration of macrophages, neutrophils,
and T cells into the liver [16]. It has been shown that
Fig. 7 Renal sections were stained CXCR3 (red), CXCL11 (green), and DAPI (blue) in non-conA-vehicle, conA-vehicle and conA-PF mice. Arrowhead
indicates there is no interaction between CXCR3 and CXCL11. Arrow indicates binding of CXCR3 and CXCL11 and interactions (×400, n = 3).
PF (30 mg/kg) was administered orally 2 h before injection of conA or vehicle for 8 h
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conA-induced liver injury depends on the production of
inflammatory cytokines and chemokines, such as tumour
necrosis factor-α (TNF-α) and IL1β [17]. Thus, macro-
phage infiltration has been considered to be a hallmark
of all forms of injury [4, 18]. Macrophage deletion causes
a decrease in pro-inflammatory cytokines and liver in-
jury is suppressed in the conA mouse model [19]. These
results demonstrate that macrophages are involved in
the production of pro-inflammatory cytokines and
played an important role in conA-induced liver injury
[20]. It was reported that one of the initial events of
renal disease was macrophage infiltration into the kidney
[21, 22]. The results showed that CD68-positive macro-
phages increased significantly in kidneys 8 h after conA
administration, meanwhile, the inflammatory cytokines
such as IL1β and MCP1 increased notably in the dam-
aged kidneys. However, surprisingly, the results showed
that IL1β and MCP1 originated mostly from tubular epi-
thelial cells, and not macrophages. These results are
consistent with other reports [23, 24].
CXCR3 was not expressed in tubular epithelial cells,
unlike IL1β and MCP1, and the immunofluorescent
staining demonstrated that almost all of the macro-
phages could express CXCR3. This result indicates that
CXCR3 may play an important role in macrophage infil-
tration. It has been suggested that CXCR3 and its li-
gands is one of the most important chemokine axes that
promotes the arrival of cells into inflamed tissues [11].
This receptor interacts with three ligands: CXCL9,
CXCL10, and CXCL11 [25]. However, in our preliminary
experiments using real-time PCR analysis, CXCR9 and
CXCR10 did not significantly increase 8 h after conA
stimulation compared with non-conA mice (data not
shown here), indicating that CXCL9 and CXCL10 may
not be important in conA-induced renal damage. CXCL11
increased more than seven-fold in conA-vehicle mice
compared with non-conA mice. Importantly, CXCL11
binds to CXCR3 with a much higher affinity than it
does CXCL9 and CXCL10 [25]. Our results showed
that CXCL11 was strong stained in tubular epithelial
cells and was bound to CXCR3 after conA stimula-
tion. Combined with these results it could be demon-
strated that the CXCR3/CXCL11 signalling axis was
over-activated and played a key role in macrophage
infiltration in the kidneys in conA-treated mice.
Paeoniflorin is one of the principal bioactive compo-
nents derived from the root of P. lactiflora Palls/Paeoniae
Radix, a traditional Chinese herbal medicine which has
been widely used in the treatment of liver and renal dis-
eases. It has been reported that PF is widely used in the
treatment of central nervous system diseases and serves as
an antioxidant to protect neurons against oxidative stress
[5]. PF is also able to alleviate acute lung injury, and the
underlying mechanisms are probably attributed to a
decrease in the production of pro-inflammatory cytokines
through down-regulating the activation of p38, JNK, and
NF-κB pathways in lung tissues [26]. We previously re-
ported that PF administration attenuated DMN-induced
liver fibrosis by regulating macrophage activation in the
main organs [9]. In this study, PF had positive effects on
liver function and renal function, with histopathological
improvement at doses of 30 mg/kg and 150 mg/kg. Pre-
treatment with PF significantly reduced macrophage infil-
tration and expression of pro-inflammatory cytokines
IL1β and MCP1. PF inhibited the elevated expression of
CXCR3 and CXCL11 and also suppressed the interactions
between CXCR3 and CXCL11.
Conclusion
In summary, the data presented in this study demon-
strates that PF has a protective effect on conA-induced
renal damage in mice, and this effect may be attributed,
at least in part, to its inhibition of CXCR3/CXCL11-me-
diated macrophage infiltration.
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